Differentiated plasma cell myeloma presenting as a solitary spinal amyloidoma: A case report, possible pitfall and review to the literature.
Brawanski N et al. Clin Neurol Neurosurg. 2015 Jun 10;137:1-4. doi: 10.1016/j.clineuro.2015.05.027. [Epub ahead of print].
Regulatory Perspective on Minimal Residual Disease Flow Cytometry Testing in Multiple Myeloma.
Gormley NJ et al. Cytometry B Clin Cytom. 2015 Jun 23. doi: 10.1002/cyto.b.21268. [Epub ahead of print].
Persistent Disparities in Adult Hematopoietic Cell Transplantation.
Crockett DG et al. Curr Hematol Malig Rep. 2015 Jun 24. [Epub ahead of print].
Treatment for patients with newly diagnosed multiple myeloma in 2015.
Mateos MV et al. Blood Rev. 2015 Jun 12. pii: S0268-960X(15)00043-0. doi: 10.1016/j.blre.2015.06.001. [Epub ahead of print].
Bendamustine in multiple myeloma.
Gentile M et al. Eur J Haematol. 2015 Jun 18. doi: 10.1111/ejh.12609. [Epub ahead of print].
Multiple myeloma: Mama, I’m coming home.
Danovi S. Nat Rev Cancer. 2015 Jul;15(7):384-5. doi: 10.1038/nrc3980. Epub 2015 Jun 18.
Case 8-2015: A Man with Multiple Myeloma, Skin Tightness, Arthralgias, and Edema.
Wigley F et al. N Engl J Med. 2015 Jun 18;372(25):2466. doi: 10.1056/NEJMc1504514.
Case 8-2015: A Man with Multiple Myeloma, Skin Tightness, Arthralgias, and Edema.
Han F. N Engl J Med. 2015 Jun 18;372(25):2465. doi: 10.1056/NEJMc1504514#SA1.
Case 8-2015: A Man with Multiple Myeloma, Skin Tightness, Arthralgias, and Edema.
Bachmeyer C et al. N Engl J Med. 2015 Jun 18;372(25):2465-6. doi: 10.1056/NEJMc1504514#SA2.
Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients.
Wang J et al. Onco Targets Ther. 2015 Jun 2;8:1277-84. doi: 10.2147/OTT.S65762. eCollection 2015.
Synthetic lethal approaches exploiting DNA damage in aggressive myeloma.
Cottini F et al. Cancer Discov. 2015 Jun 16. pii: CD-14-0943. [Epub ahead of print].
Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.
Merz M et al. J Cancer Res Clin Oncol. 2015 Jun 12. [Epub ahead of print].
Coexistent B-cell and plasma cell neoplasms: a case series providing novel clinical insight.
Jamani K et al. Leuk Lymphoma. 2015 Jun 12:1-17. [Epub ahead of print].
Smoldering multiple myeloma.
Mateos MV et al. Hematol Oncol. 2015 Jun;33 Suppl 1:33-7. doi: 10.1002/hon.2213.
Thalidomide-induced teratogenesis: History and mechanisms.
Vargesson N. Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56. doi: 10.1002/bdrc.21096. Epub 2015 Jun 4.
Hospital population screening reveals overrepresentation of CD5- monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type.
Voigtlaender M et al. Ann Hematol. 2015 Jun 5. [Epub ahead of print].
Monoclonal gammopathy in HIV-1 infected patients: factors associated with disappearance under long-term antiretroviral therapy.
Casanova ML et al. J Acquir Immune Defic Syndr. 2015 Jun 1. [Epub ahead of print].
Prevalence and clinical significance of abnormal serum free kappa/lambda light chain ratio in patients with chronic kidney disease.
Niewmierzycka A et al. Pol Arch Med Wewn. 2015 Jun 3. pii: AOP_15_054. [Epub ahead of print].
Health-related quality of life in patients with multiple myeloma – does it matter?
Kvam AK et al. Haematologica. 2015 Jun;100(6):704-5. doi: 10.3324/haematol.2015.127860.
Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database.
Shah GL et al. Biol Blood Marrow Transplant. 2015 May 30. pii: S1083-8791(15)00336-5. doi: 10.1016/j.bbmt.2015.05.013. [Epub ahead of print].
Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country.
Ali N et al. Stem Cells Transl Med. 2015 Jun 1. pii: sctm.2015-0015. [Epub ahead of print].
FDA approves new agent for multiple myeloma.
Fenichel MP. J Natl Cancer Inst. 2015 Jun 1;107(6):djv165. doi: 10.1093/jnci/djv165. Print 2015 Jun.
Geriatric Assessment of Older Adults With Cancer During Unplanned Hospitalizations: An Opportunity in Disguise.
Mariano C et al. Oncologist. 2015 Jun 1. pii: theoncologist.2015-0023. [Epub ahead of print].
Promising therapies in multiple myeloma.
Bianchi G et al. Blood. 2015 Jun 1. pii: blood-2015-03-575365. [Epub ahead of print].
Management of Elderly Patients with Plasma Cell Myeloma.
Campagnaro EL et al. Drugs Aging. 2015 Jun;32(6):427-42. doi: 10.1007/s40266-015-0265-x.